Home > Healthcare > Medical Devices > Diagnostic Devices > Oncology Based Molecular Diagnostics Market

Oncology Based Molecular Diagnostics Market Share

Report ID: GMI8602
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Oncology Based Molecular Diagnostics Market Share

The oncology based molecular diagnostics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Oncology Based Molecular Diagnostics Market Companies

Some of the eminent market participants operating in the oncology based molecular diagnostics industry include:

Abbott Laboratories
Agilent Technologies, Inc.
Becton, Dickinson and Company
Biocartis Group NV
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann La Roche Ltd.
Hologic, Inc.
Illumina, Inc.
QIAGEN N.V.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oncology based molecular diagnostics market size was USD 2.2 billion in 2023 and is expected to reach over USD 3.3 billion by 2032 owing to the rising cases of cancer from population aging, lifestyle changes, and the rising prevalence of risk factors such as smoking and obesity worldwide.

The reagents and kits segment is expected to reach USD 2 billion by 2032 due to reagents and kits being indispensable components for molecular diagnostic assays.

North America oncology based molecular diagnostics industry recorded 40.6% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to high prevalence of cancer in the region.

Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann La Roche Ltd., Hologic, Inc., Illumina, Inc., QIAGEN N.V., Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific Inc., are some of the major oncology based molecular diagnostics companies worldwide.